ASCEND, NCT05402371: A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis |
|
|
| Active, not recruiting | 2 | 120 | Europe, US, RoW | Rencofilstat, CRV431, Placebo | Hepion Pharmaceuticals, Inc. | Nonalcoholic Steatohepatitis (NASH), Fibrosis, Liver, NAFLD | 05/25 | 09/25 | | |